Repository of Research and Investigative Information

Repository of Research and Investigative Information

Ilam University of Medical Sciences

MIG1 Glucose Repression in Metabolic Processes of Saccharomyces cerevisiae: Genetics to Metabolic Engineering

Mon Sep 26 13:05:15 2022

(2019) MIG1 Glucose Repression in Metabolic Processes of Saccharomyces cerevisiae: Genetics to Metabolic Engineering. Avicenna journal of medical biotechnology. pp. 215-220. ISSN 2008-2835 (Print) 2008-2835 (Linking)

Full text not available from this repository.

Official URL: https://www.ncbi.nlm.nih.gov/pubmed/31379993

Abstract

Background: Although Saccharomyces cerevisiae has several industrial applications, there are still fundamental problems associated with sequential use of carbon sources. As such, glucose repression effect can direct metabolism of yeast to preferably anaerobic conditions. This leads to higher ethanol production and less efficient production of recombinant products. The general glucose repression system is constituted by MIG1, TUP1 and SSN6 factors. The role of MIG1 is known in glucose repression but the evaluation of effects on aerobic/anaerobic metabolism by deletion of MIG1 and constructing an optimal strain brand remains unclear and an objective to be explored. Methods: To find the impact of MIG1 in induction of glucose-repression, the Mig1 disruptant strain (DeltaMIG1) was produced for comparing with its congenic wild-type strain (2805). The analysis approached for changes in the rate of glucose consumption, biomass yield, cell protein contents, ethanol and intermediate metabolites production. The MIG1 disruptant strain exhibited 25 glucose utilization, 12 biomass growth rate and 22 protein content over the wild type. The shift to respiratory pathway has been demonstrated by 122.86 and 40 increase of glycerol and pyruvate production, respectively as oxidative metabolites, while the reduction of fermentative metabolites such as acetate 35.48 and ethanol 24. Results: Results suggest that DeltaMIG1 compared to the wild-type strain can significantly present less effects of glucose repression. Conclusion: The constructed strain has more efficient growth in aerobic cultivations and it can be a potential host for biotechnological recombinant yields and industrial interests.

Item Type: Article
Creators:
CreatorsEmail
Alipourfard, I.UNSPECIFIED
Datukishvili, N.UNSPECIFIED
Bakhtiyari, S.UNSPECIFIED
Haghani, K.UNSPECIFIED
Di Renzo, L.UNSPECIFIED
de Miranda, R. C.UNSPECIFIED
Mikeladze, D.UNSPECIFIED
Keywords: Homologous recombination Metabolic pathways Saccharomyces cerevisiae Yeasts
Divisions:
Page Range: pp. 215-220
Journal or Publication Title: Avicenna journal of medical biotechnology
Journal Index: Pubmed
Volume: 11
Number: 3
ISSN: 2008-2835 (Print) 2008-2835 (Linking)
Depositing User: مهندس مهدی شریفی
URI: http://eprints.medilam.ac.ir/id/eprint/2461

Actions (login required)

View Item View Item